JESSICA HAWKINS: Open Payments
NPI 1841862901 · BELOIT, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 12 payments from 7 companies in 2025. Trend: 2023 $253 · 2024 $265 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Amgen Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Viatris Specialty LLC | 1 | $17 |
Products named: LEQVIO, VRAYLAR, EVENITY, JARDIANCE, Dexcom G6 Transmitter, CAMZYOS, YUPELRI, TEFLARO.
Industry payments across KS — which companies pay providers there.
